Chronic Salmonella enterica serovar typhimurium-induced colitis and cholangitis in streptomycin-pretreated Nramp1+/+ mice

Infection and Immunity

Volumn 74, Issue 9, 2006, Pages 5047-5057

  Stecher, Bärbel ^a   Paesold, Günther ^a,d   Barthel, Manja ^a   Kremer, Marcus ^c   Jantsch, Jonathan ^b   Stallmach, Thomas ^b   Heikenwalder, Mathias ^b   Hardt, Wolf Dietrich ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BILE DUCT; CELL INFILTRATION; CHOLANGITIS; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPT ABCESS; CRYPT BRANCHING; CRYPT CELL; DISEASE COURSE; DRUG INDUCED DISEASE; ENTEROBACTERIACEAE; EPITHELIUM; FEMALE; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HOST SUSCEPTIBILITY; INFLAMMATION; INTESTINE; INTESTINE ULCER; MALE; MOUSE; MOUSE STRAIN; MUCOSA; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; SUBMUCOSA; SYSTEMIC DISEASE; TISSUE REGENERATION; TYPHOID FEVER;

ANIMALS; CATION TRANSPORT PROTEINS; CHOLANGITIS; CHRONIC DISEASE; COLITIS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; MALE; MICE; MICE, INBRED DBA; MICE, MUTANT STRAINS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; STREPTOMYCIN;

EID: 33748038043     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00072-06     Document Type: Article

References (42)

1. Barthel, M., S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde. M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:2839-2858.
2. Bellamy, R. 1999. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect. 1:23-27.
3. Benjamin, W. H., Jr., P. Hall, S. J. Roberts, and D. E. Briles. 1990. The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing. J. Immunol. 144:3143-3151.
4. Boyd, J. F. 1985. Pathology of the alimentary tract in Salmonella typhimurium food poisoning. Gut 26:935-944.
5. Carpenter, H. A., and N. J. Talley. 2000. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am. J. Gastroenterol. 95:878-896.
6. Carter, P. B., and F. M. Collins. 1974. The route of enteric infection in normal mice. J. Exp. Med. 139:1189-1203.
7. Cheminay, C., A. Mohlenbrink, and M. Hensel. 2005. Intracellular Salmonella inhibit antigen presentation by dendritic cells. J. Immunol. 174:2892-2899.
8. Coburn, B., Y. Li, D. Owen, B. A. Vallance, and B. B. Finlay. 2005. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect. Immun. 73:3219-3227.
9. Coombes, B. K., B. A. Coburn, A. A. Potter, S. Gomis, K. Mirakhur, Y. Li, and B. B. Finlay. 2005. Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect. Immun. 73:7161-7169.
10. Crum, N. F. 2003. Current trends in typhoid fever. Curr. Gastroenterol. Rep. 5:279-286.
11. Cuellar-Mata, P., N. Jabado, J. Liu, W. Furuya, B. B. Finlay, P. Gros, and S. Grinstein. 2002. Nramp1 modifies the fusion of Salmonella typhimurium-containing vacuoles with cellular endomembranes in macrophages. J. Biol. Chem. 277:2258-2265.
12. Gros, P., E. Skamene, and A. Forget. 1981. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J. Immunol. 127:2417-2421.
13. Gruenheid, S., E. Pinner, M. Desjardins, and P. Gros. 1997. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 185:717-730.
14. Hapfelmeier, S., K. Ehrbar, B. Stecher, M. Barthel, M. Kremer, and W. D. Hardt. 2004. Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72:795-809.
15. Hapfelmeier, S., and W. D. Hardt. 2005. A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol. 13:497-503.
16. Hapfelmeier, S., B. Stecher, M. Barthel, M. Kremer, A. Müller, M. Heikenwalder, T. Stallmach, M. Hensel, K. Pfeffer, S. Akira, and W. D. Hardt. 2005. The Salmonella pathogenicity island (SPI)-1 and SPI-2 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J. Immunol. 174:1675-1685.
17. Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
18. Hormaeche, C. E. 1979. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37:311-318.
19. Hormaeche, C. E., K. A. Harrington, and H. S. Joysey. 1985. Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex. J. Infect. Dis. 152:1050-1056.
20. Jimenez-Saenz, M., B. J. Gomez-Rodriguez, I. Carmona, J. Rebollo, Y. Torres, J. Rodriguez-Banos, and J. M. Herrerias-Gutierrez. 2001. Salmonella dublin infection: a rare cause of spontaneous bacterial peritonitis and chronic colitis in alcoholic liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 13:587-589.
21. Karrer, U., A. Althage, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 2000. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect. Eur. J. Immunol. 30:2799-2807.
22. MacFaul, G. R., and R. W. Chapman. 2004. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 20:275-280.
23. Malo, D., K. Vogan, S. Vidal, J. Hu, M. Cellier, E. Schurr, A. Fuks, N. Bumstead, K. Morgan, and P. Gros. 1994. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23:51-61.
24. Miller, C. P., and M. Bohnhoff. 1963. Changes in the mouse's enteric microflora associated with enhanced susceptibility to Salmonella infection following streptomycin treatment. J. Infect. Dis. 113:59-66.
25. +/+ mice and can be reactivated by 1FNγ neutralization. J. Exp. Med. 199:231-241.
26. Morpeth, S. C., and N. M. Thielman. 2006. Diarrhea in patients with AIDS. Curr. Treat. Options Gastroenterol. 9:23-37.
27. Nauciel, C., E. Ronco, J. L. Guenet, and M. Pla. 1988. Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice. Infect. Immun. 56:2407-2411.
28. O'Brien, A. D., B. A. Taylor, and D. L. Rosenstreich. 1984. Genetic control of natural resistance to Salmonella typhimurium in mice during the late phase of infection. J. Immunol. 133:3313-3318.
29. Que, J. U., and D. J. Hentges. 1985. Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice. Infect. Immun. 48:169-174.
30. Robbins, S., V. P. Chuang, and T. Hersh. 1988. The development of hepatobiliary cancer in a carrier of Salmonella typhus. Am. J. Gastroenterol. 83:675-678.
31. Sachdev, H. P., V. Chadha, V. Malhotra, A. Verghese, and R. K. Puri. 1993. Rectal histopathology in endemic Shigella and Salmonella diarrhea. J. Pediatr. Gastroenterol. Nutr. 16:33-38.
32. Salcedo, S. P., M. Noursadeghi, J. Cohen, and D. W. Holden. 2001. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell. Microbiol. 3:587-597.
33. Stecher, B., S. Hapfelmeier, C. Muller, M. Kremer, T. Stallmach, and W. D. Hardt. 2004. Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72:4138-4150.
34. Stecher, B., A. J. Macpherson, S. Hapfelmeier, M. Kremer, T. Stallmach, and W. D. Hardt. 2005. Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin. Infect. Immun. 73:3228-3241.
35. Suar, M., J. Jantsch, S. Hapfelmeier, M. Kremer, T. Stallmach, P. A. Barrow, and W. D. Hardt. 2006. Virulence of broad- and narrow-host-range Salmonella enterica serovars in the streptomycin-pretreated mouse model. Infect. Immun. 74:632-644.
36. Talwalkar, J. A., and K. D. Lindor. 2005. Primary sclerosing cholangitis. Inflamm. Bowel Dis. 11:62-72.
37. Tannock, G. W., and D. C. Savage. 1976. Indigenous microorganisms prevent reduction in cecal size induced by Salmonella typhimurium in vaccinated gnotobiotic mice. Infect. Immun. 13:172-179.
38. Vidal, S., P. Gros, and E. Skamene. 1995. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukoc. Biol. 58:382-390.
39. Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 73:469-485.
40. Vidal, S. M., E. Pinner, P. Lepage, S. Gauthier, and P. Gros. 1996. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J. Immunol. 157:3559-3568.
41. Wigley, P. 2004. Genetic resistance to Salmonella infection in domestic animals. Res. Vet. Sci. 76:165-169.
42. Yrlid, U., and M. J. Wick. 2002. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 169:108-116.